Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cryofocus Medtech (Shanghai) Co's quarterly market cap
declined
from Dec. 2024 (HK$1,951.14 Mil) to Jun. 2025 (HK$1,209.90 Mil) but then
increased
from Jun. 2025 (HK$1,209.90 Mil) to Dec. 2025 (HK$1,645.08 Mil).
Cryofocus Medtech (Shanghai) Co's annual market cap
declined
from Dec. 2023 (HK$4,500.05 Mil) to Dec. 2024 (HK$1,951.14 Mil) and
declined
from Dec. 2024 (HK$1,951.14 Mil) to Dec. 2025 (HK$1,645.08 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Cryofocus Medtech (Shanghai) Co's Enterprise Value for Today is HK$670.78 Mil.
Cryofocus Medtech (Shanghai) Co (HKSE:06922) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Cryofocus Medtech (Shanghai) Co Market Cap Related Terms
Cryofocus Medtech (Shanghai) Co Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:06922 vs ABT, SYK, MDT: Market Cap Comparison
For the Medical Devices subindustry, Cryofocus Medtech (Shanghai) Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cryofocus Medtech (Shanghai) Co Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Cryofocus Medtech (Shanghai) Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Cryofocus Medtech (Shanghai) Co's Market Cap falls into.
Cryofocus Medtech (Shanghai) Co Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cryofocus Medtech (Shanghai) Co (HKSE:06922) has a Market Cap of HK$682.73 Mil as of Sep. 09, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Cryofocus Medtech (Shanghai) Co and its competitors. According to the industry distribution chart, Cryofocus Medtech (Shanghai) Co ranks #467 out of 859 companies in the Medical Devices & Instruments industry, placing it in the top 54.4%.
Is Cryofocus Medtech (Shanghai) Co's Market Cap too high?
Cryofocus Medtech (Shanghai) Co's current Market Cap is HK$682.73 Mil. Based on the distribution chart, Cryofocus Medtech (Shanghai) Co ranks #467 out of 859 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Cryofocus Medtech (Shanghai) Co has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Cryofocus Medtech (Shanghai) Co's Market Cap compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Cryofocus Medtech (Shanghai) Co ranks #467 out of 859 companies for Market Cap. This places Cryofocus Medtech (Shanghai) Co in the lower half of its industry. The industry median Market Cap is 121.83. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 121.83, based on 859 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Cryofocus Medtech (Shanghai) Co and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 121.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cryofocus Medtech (Shanghai) Co's current Market Cap is HK$682.73 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cryofocus Medtech (Shanghai) Co stock overvalued right now?
Based on GuruFocus' analysis, Cryofocus Medtech (Shanghai) Co (HKSE:06922) is currently considered Possible Value Trap. The stock's GF Value™ is HK$21.01, compared to a current price of HK$2.79 — trading 86.7% below its estimated fair value. The current Market Cap is HK$682.73 Mil. Cryofocus Medtech (Shanghai) Co's overall GF Score™ is 61/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Cryofocus Medtech (Shanghai) Co (HKSE:06922), the current Market Cap is HK$682.73 Mil as of Sep. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cryofocus Medtech (Shanghai) Co (HKSE:06922) Overvalued in 2026?
Based on GuruFocus' analysis, Cryofocus Medtech (Shanghai) Co stock appears to be undervalued.
The current stock price of HK$2.79 is trading 86.7% below its estimated GF Value™ of HK$21.01.
GuruFocus considers Cryofocus Medtech (Shanghai) Co to be Possible Value Trap.
Key valuation signals for HKSE:06922:
Market Cap: HK$682.73 Mil
GF Value™: HK$21.01 vs. price of HK$2.79 (86.7% below fair value)
No single metric tells the full story. See the HKSE:06922 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cryofocus Medtech (Shanghai) Co Ltd is a medical device company engaged in the research and development, manufacture, and sale of cryoablation minimally invasive interventional treatment technology and related medical products. The company uses liquid nitrogen as the main cryogenic source for cryotherapy systems by leveraging liquid nitrogen cryoablation technology and flexible catheter technology. The products offered by the company include: Bladder Cryoablation System, Pulmonary Nodule Localization Needle, and Endoscopic Clip for Anastomosis, among others. Geographically, the company's revenue is generated from the sale of medical consumables and devices in the Chinese Mainland.
61GF Score
Get the complete analysis for HKSE:06922
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:06922 has been successfully added to your 
